Clinical characteristics and outcome of dogs with presumed primary renal lymphoma

The Journal of Small Animal Practice
A TaylorA Lara-Garcia

Abstract

To characterise the presentation, clinicopathologic data and outcome of 29 dogs with presumed primary renal lymphoma. Retrospective analysis of medical records of dogs with suspected primary renal lymphoma from 11 institutions. All dogs were substage b, and lethargy and gastrointestinal signs were common presenting complaints, as were azotaemia (n=25; 86%) and erythrocytosis (n=15; 51%) on biochemical testing. Ultrasonography typically revealed bilateral renal lesions (n=23; 79%), renomegaly (n=22; 76%) and abdominal lymphadenopathy (n=14; 48%). Chemotherapy was the only treatment in 23 dogs, of which 11 responded, all considered partial responses. For all dogs the median progression-free survival and median overall survival times were 10 days (range: 1 to 126) and 12 days (range: 1 to 212), respectively, and for dogs that responded to chemotherapy 41 days (range: 10 to 126) and 47 days (range: 10 to 212), respectively. Primary renal lymphoma in dogs appears to be associated with a poor prognosis and short-lived response to chemotherapy.

References

Nov 1, 1977·Veterinary Pathology·G B Baskin, A De Paoli
Apr 1, 1989·Journal of Veterinary Internal Medicine·C G CoutoJ Rojko
May 1, 1988·AJR. American Journal of Roentgenology·D S HartmanS M Goldman
Jan 1, 1980·Journal of Cancer Research and Clinical Oncology·H DrepperD Obst
Apr 1, 1980·Australian Veterinary Journal·L Winsor
Aug 1, 1993·The Journal of Veterinary Medical Science·D ZhaoH Ogawa
Jan 1, 1996·Urologia Internationalis·S Saito
Dec 23, 1998·Australian Veterinary Journal·L J GaborP J Canfield
Aug 19, 1999·Australian Veterinary Journal·L J GaborR Malik
Mar 31, 2000·Annals of Hematology·S GopalM T Elghetany
Sep 21, 2002·Journal of the South African Veterinary Association·E P Lane, R G Lobetti
Dec 19, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A D G KrolE M Noordijk
Mar 26, 2003·The Journal of Small Animal Practice·B D X LascellesW S Dernell
Feb 27, 2004·The Journal of Small Animal Practice·M N SaridomichelakisA F Koutinas
Sep 13, 2005·Pediatric Blood & Cancer·Amy M BeckerMichel Baum
Jun 6, 2006·New Zealand Veterinary Journal·D J BatchelorL Blackwood
Nov 3, 2007·Journal of the American Animal Hospital Association·Joseph David FrankMatti Kiupel
Mar 18, 2008·Journal of the American Veterinary Medical Association·Daniela SimonIngo Nolte
Nov 7, 2009·The Journal of Small Animal Practice·S S TaylorJ M Dobson
Mar 17, 2010·Veterinary and Comparative Oncology·D M VailUNKNOWN Veterinary Cooperative Oncology Group
Jan 18, 2011·Journal of the American Veterinary Medical Association·Melanie A BreshearsJustin D Thomason
Feb 12, 2011·Journal of the American Animal Hospital Association·Alexandra S DurnoDorothee Bienzle
Oct 4, 2011·Journal of the American Veterinary Medical Association·Gillian DankGilad Segev
Apr 1, 1994·The Veterinary Quarterly·E Teske
Mar 19, 2014·Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association·Angela J TaylorLivia Benigni
Jun 26, 2014·Journal of Gastrointestinal Cancer·Meryem AitelhajHassan Errihani
Aug 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonT Andrew Lister
Dec 6, 2014·The Veterinary Journal·M ZandvlietJ A Mol
Sep 1, 2016·Journal of Endourology Case Reports·Jacob JippBradley Schwartz
May 17, 2017·Veterinary and Comparative Oncology·P M BrownV Langova

❮ Previous
Next ❯

Citations

Apr 16, 2021·BMC Veterinary Research·Sara KotbJennifer L Johns

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.